Wasatch Advisors Inc Journey Medical Corp Transaction History
Wasatch Advisors Inc
- $17.9 Billion
- Q3 2025
A detailed history of Wasatch Advisors Inc transactions in Journey Medical Corp stock. As of the latest transaction made, Wasatch Advisors Inc holds 1,306,272 shares of DERM stock, worth $10.4 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,306,272
Previous 1,152,059
13.39%
Holding current value
$10.4 Million
Previous $8.27 Million
11.81%
% of portfolio
0.05%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding DERM
# of Institutions
69Shares Held
8.98MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$14.7 Million0.6% of portfolio
-
Opaleye Management Inc. Boston, MA971KShares$7.71 Million1.15% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$6.87 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA615KShares$4.88 Million0.0% of portfolio
-
Summit Financial, LLC Parsippany, NJ380KShares$3.02 Million0.04% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $92.1M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...